50 results
6-K
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
enter into;
the extent to which we are obligated to reimburse, or entitled to reimbursement of, clinical trial costs under collaboration agreements
F-3ASR
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
be necessary or desirable to develop, manufacture or commercialize our product candidates;
the pricing and reimbursement of the product candidates … regulations, pre-marketing regulatory requirements, pricing, reimbursement and cost-containment regulations, and ongoing regulation of approved
F-3ASR
EX-4.4
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
Hold Securities
Section 7.05
Moneys Held in Trust
Section 7.06
Compensation and Reimbursement
Section 7.07
Reliance on Officer’s Certificate
Section … such as it may agree with the Company to pay thereon.
Section 7.06 Compensation and Reimbursement.
(a) The Company shall pay to the Trustee for each of its
6-K
sslz4vq7z9s0djlytw
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
6-K
ka5qt3c ge
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
F-3ASR
jawekf2uhr4cqy qbp
26 May 23
Automatic shelf registration (foreign)
9:01am
424B5
ga54n7 xe
8 May 23
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
vnl7e9dn 0i
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
6-K
1gv bynlfp3w6
3 Oct 22
Legend Biotech Corporation 6-K
4:02pm
6-K
EX-10.1
897wjsjr25nghf
3 Oct 22
Legend Biotech Corporation 6-K
4:02pm
6-K
EX-10.1
ev245w2
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
6-K
96nvsc30my72rqaqvavq
4 Aug 22
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
4:18pm
424B5
4derp2m3z
27 Jul 22
Prospectus supplement for primary offering
4:32pm